Pacific Biosciences Of California (PACB) Construction in Progress (2016)
Pacific Biosciences Of California (PACB) posted Construction in Progress of $5.8 million for Q4 2016.
Powered by 
Analysis
Pacific Biosciences Of California (PACB) Construction in Progress (2016) Analysis & Trends
Pacific Biosciences Of California has reported Construction in Progress for 1 years, with the latest figure at $5.8 million in Q4 2016.
- On a quarterly basis, Construction in Progress changed N/A year-over-year to $5.8 million in Q4 2016; TTM through Dec 2016 was $5.8 million, a N/A change from a year earlier, with the FY2016 full-year figure at $5.8 million, changed N/A from the prior year.
- Construction in Progress was $5.8 million for Q4 2016 at Pacific Biosciences Of California.
- The five-year high for Construction in Progress was $5.8 million in Q4 2016, with the low at $5.8 million in Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | - |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | - |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | - |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | - |
| 10 | Pacific Biosciences Of California | 400.74 Mn | 163.87 Mn | 12.64 Mn | - |